Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

414
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

222
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

PERITONEAL DIALYSIS PAST, PRESENT, AND FUTURE

Pages

  171-182

Abstract

 Approximately, 10% to 15% of patients with END-STAGE RENAL DISEASE are on PERITONEAL DIALYSIS (PD) worldwide, with a dramatic difference in the use of PD among various countries. Recent data show a survival benefit of PD over hemodialysis which is maintained up to the 3rd year. The quality of life studied by various models is as good as, if not better than, that in patients on hemodialysis, for at least the first 2 years. In most countries that locally manufacture PD solutions, PD is significantly cheaper than hemodialysis. Several studies have found a better immediate graft function, lower rate of delayed graft function, and lower use of immunosuppressive medication after kidney transplantation in patients previously on PD compared to those on hemodialysis. There is a significantly lower rate of hepatitis C and hepatitis B infections in patients on PD compared to those on hemodialysis. Longer maintenance of residual renal function in PD compared to hemodialysis adds to the lower morbidity and the survival benefit of PD mentioned above. Many developments in the prevention of the causes of technique failure, including measures to prevent serious peritonitis episodes and new biocompatible PD solutions, together with the possible advantages of some types of catheters and implantation techniques, encourage us to believe that we can offer successful long-term PD in the near future. Overall, the new insight into the pathogenesis of peritoneal membrane changes, the response of the industry to this knowledge by producing new biocompatible PD solutions, the decrease in the peritonitis rate and the introduction of assisted PD at home encourages us to believe that the future of PD is indeed bright.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    OREOPOULOS, D., OSSAREH, SH., & THODIS, E.. (2008). PERITONEAL DIALYSIS PAST, PRESENT, AND FUTURE. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 2(4), 171-182. SID. https://sid.ir/paper/308708/en

    Vancouver: Copy

    OREOPOULOS D., OSSAREH SH., THODIS E.. PERITONEAL DIALYSIS PAST, PRESENT, AND FUTURE. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)[Internet]. 2008;2(4):171-182. Available from: https://sid.ir/paper/308708/en

    IEEE: Copy

    D. OREOPOULOS, SH. OSSAREH, and E. THODIS, “PERITONEAL DIALYSIS PAST, PRESENT, AND FUTURE,” IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), vol. 2, no. 4, pp. 171–182, 2008, [Online]. Available: https://sid.ir/paper/308708/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top